Multilingual Patient Communications: Parting Lessons of the Pandemic
As the World Health Organization joins the United States in calling an end to the pandemic, few want more than to move on from a time of unrelenting challenges, but that timing may not be so fortuitous when it comes to capturing its most important lessons for...
MedTech and Medical Device Localization: Leveraging ISO 13485 for Multilingual Quality Management
With so much of MedTech resembling a medical device, and with more medical devices incorporating software and other digital components, it is ever harder to define what is a MedTech and what is a medical device localization project. With the possibility some projects...
Linguistic Validation for eClinical Patient Questionnaires: Driving Patient Centricity Through eCOA Translations
When it comes to setting up a foundation for diverse, patient-centric clinical trials, linguistic validation is an essential localization practice that can help prepare patient questionnaires for participants in diverse global regions, an essential to succeeding in...
Reducing Clinical Trial Delays with IVD Translations
When conducting clinical trials in Europe and around the world, accurate and effective IVD translations help mitigate clinical trial delays that stand in the way of device approval. In vitro diagnostic medical devices (IVDs), also called in vitro diagnostic products,...
Can Clinical Trial Translations Improve Sponsor Diversity Index?
Following the premiere of Bioethics International’s new diversity index in 2023, how can clinical trial translations improve a company’s future rating? Diversity in clinical trials has been a hot topic in recent years, even prompting the U.S. Food and Drug...
Personalization and Patient-Centricity in Pharmaceutical Labeling Translations
Among the many steps it takes to bring a drug to market, pharmaceutical labeling translations may seem like one small hurdle to overcome on the way to approval. Medical translation of pharmaceutical labels, which can include labels on the carton or package and a host...
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com